PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring.
Mediplus, a leader in medical device innovation, has unveiled its pioneering 5-Way TIVA Set at SIVA 2024, the annual scientific meeting hosted by The Society for Intravenous Anaesthesia.
The device is set to debut at the upcoming GISE 2024 and London Valves 2024 conferences.
Canon Medical Systems USA today announced the commercial launch of its Vantage Galan 3T/Supreme Edition MRI system.
GE HealthCare (Nasdaq:GEHC) today announced its new Pristina Via mammography system designed to enhance the screening experience.
EchoGo Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an underdiagnosed cause of heart failure.
The device has sold well in Europe, where the company said it has a 60% market share, but will be the first product of its type available in the U.S.
Stereotaxis (NYSE:STXS) announced today that its Genesis surgical robot received regulatory approval in China.
Globus Medical (NYSE:GMED) announced that launched its ExcelsiusHub navigation system for robotic surgical procedures.
SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ — Neurophet, an artificial intelligence (AI) solution company for brain disease, announced on the 25th that its brain MRI analysis software “Neurophet AQUA”, has obtained 510(k) clearance from U.S. Food and Drug Administration (FDA) for its newly integrated multiple sclerosis (MS) analysis functionality.